$3.68 -0.06 (-1.63%)

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA)

Sonoma Pharmaceuticals, Inc. is a healthcare company focused on developing and commercializing innovative pharmaceutical products for infection prevention and wound care. The company specializes in proprietary formulations aimed at reducing bacterial resistance and improving patient outcomes, primarily serving the eye care and wound management markets.

đźš« Sonoma Pharmaceuticals, Inc. Common Stock does not pay dividends

Company News

Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Benzinga • Avi Kapoor • July 12, 2024

Ericsson reported better-than-expected Q2 sales and issued guidance, causing its shares to rise in pre-market trading. Several other stocks also saw significant pre-market movement, both positive and negative.

Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock
Zacks Investment Research • Zacks Equity Research • June 28, 2024

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Investors Chat: Instacart IPO
The Motley Fool • [email protected] (Motley Fool Staff) • September 3, 2023

Instacart is profitable and growing. Is that enough to spark investor interest?

Top Penny Stocks Trading Mistakes to Avoid 
PennyStocks • J Dylan • June 12, 2023

Are you making these common penny stocks trading mistakes? The post Top Penny Stocks Trading Mistakes to Avoid  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Here’s why Sonoma Pharmaceuticals is up 70% on Tuesday morning
Invezz • Wajeeh Khan • September 28, 2021

Shares of Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) jumped 70% in premarket trading on Tuesday as the company launched its first-ever over-the-counter products on Amazon. Sonoma debuts in the OTC market According to the press release, Sonoma Pharmaceuticals limited its offerings to “prescription or office dispense products” available only fro...